| 1 |
Toxoplasma gondii-derived antigen modifies tumor microenvironment of Ehrlich solid carcinoma murine model and enhances immunotherapeutic activity of cyclophosphamide |
|
| | Cherine A. Ismail, Maha M. Eissa, Maha R. Gaafar, Layla K. Younis, Nahla El Skhawy | | | Medical Oncology. 2023; 40(5) | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Prophylactic antineoplastic activity of Toxoplasma gondii RH derived antigen against ehrlich solid carcinoma with evidence of shared antigens by comparative immunoblotting |
|
| | Maha M. Eissa, Maha R. Gaafar, Layla K. Younis, Cherine A. Ismail, Nahla El Skhawy | | | Infectious Agents and Cancer. 2023; 18(1) | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Rationale for Tailoring an Alternative Oncology Trial Using a Novel Gallium-Based Nanocomplex: Mechanistic Insights and Preclinical Challenges |
|
| | Nihal Mostafa, Ahmed Salem, Somaya Z. Mansour, Sawsan M. El-Sonbaty, Fatma S. M. Moawed, Eman I. Kandil | | | Technology in Cancer Research & Treatment. 2022; 21: 1533033822 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Cytotoxic and Antioxidant Potential of Chloroform Extract of Holothuria tubulosa Gmelin, 1791 |
|
| | M. Dogangünes, A. Türker, H. Günes, M. Alper | | | Russian Journal of Marine Biology. 2021; 47(6): 498 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Patient-Derived Tumor Organoids for Drug Repositioning in Cancer Care: A Promising Approach in the Era of Tailored Treatment |
|
| | Silvia Vivarelli,Saverio Candido,Giuseppe Caruso,Luca Falzone,Massimo Libra | | | Cancers. 2020; 12(12): 3636 | | | [Pubmed] [Google Scholar] [DOI] | |
|
